Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Colorectal Cancer Risk Reduction After Polypectomy: Evidence Against the National Polyp Study
Clinical Gastroenterology and Hepatology , 11/05/09
Hassan C et al. – The consistent discrepancy between the NPS results and those of the subsequent trials, including the present one, should question the opportunity of weakening the intensity of postpolypectomy follow–up, broadening the intervals between subsequent examinations, especially in those with a low–risk polyp at the index colonoscopy.
Related Articles
P73 expression and its clinical significance in colorectal cancer
Colorectal Disease, 10/19/09
Relevance Score: 68%
Surgical management of colorectal liver metastases
Community Oncology, 10/09/09
Relevance Score: 68%
Establishment of a minimally invasive program at a Veterans Affairs Medical Center leads to improved care in colorectal cancer patients
The American Journal of Surgery, 11/03/09
Relevance Score: 67%
The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials
Colorectal Disease, 10/15/09
Relevance Score: 67%
Aspirin as Colorectal Cancer Adjuvant Therapy
Gastroenterology, 10/05/09
Relevance Score: 67%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer
Case Reports in Gastroenterology, 11/25/09
Impact of Palliative Chemotherapy and Surgery on Management of Stage IV Incurable Colorectal Cancer
Annals of Surgical Oncology, 11/25/09
KRAS Mutational Status as a Predictor of Epidermal Growth Factor Receptor Inhibitor Efficacy in Colorectal Cancer
American Journal of Therapeutics, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


